Shohei Yoshiya
Overview
Explore the profile of Shohei Yoshiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iwasaki H, Itoh S, Iseda N, Tsutsui Y, Izumi T, Bekki Y, et al.
Surg Case Rep
. 2024 Nov;
10(1):258.
PMID: 39527378
Introduction: Malignant melanomas occur most commonly in the skin, mucous membranes, or choroid. Clitoral malignant melanomas are extremely rare. Stage IV malignant melanomas have a poor prognosis, and molecularly targeted...
2.
Tomino T, Itoh S, Toshima T, Yoshiya S, Bekki Y, Iseda N, et al.
Surg Today
. 2024 Sep;
PMID: 39317845
Purpose: To validate the reliability of fibrosis markers as predictors of graft survival in living donor liver transplantation (LDLT) recipients. Methods: We reviewed data retrospectively, from 163 patients who underwent...
3.
Izumi T, Toshima T, Itoh S, Yoshiya S, Bekki Y, Iseda N, et al.
Hepatol Res
. 2024 Sep;
PMID: 39276320
Aim: Reactivation of hepatitis B virus (HBV) after liver transplantation (LT) remains a problem; thus, development of more effective HBV reactivation prophylaxis is desirable. We evaluated the efficacy of a...
4.
Ishikawa T, Itoh S, Toshima T, Yoshiya S, Bekki Y, Iseda N, et al.
Surg Case Rep
. 2024 Sep;
10(1):210.
PMID: 39249546
Background: Fontan-associated liver disease (FALD) encompasses hepatic complications following the Fontan procedure, ranging from fibrosis to hepatocellular carcinoma (HCC). Despite advancements in surgical techniques and perioperative care, robot-assisted laparoscopic hepatectomy...
5.
Iseda N, Itoh S, Toshima T, Yoshiya S, Bekki Y, Tsutsui Y, et al.
Surg Today
. 2024 Aug;
PMID: 39192138
Background And Purpose: In recent years, new systemic therapies have been developed for hepatocellular carcinoma (HCC). The aim of this study was to evaluate the prognosis of patients with unresectable...
6.
Toshida K, Itoh S, Iseda N, Izumi T, Bekki Y, Yoshiya S, et al.
Ann Surg Oncol
. 2024 Aug;
31(13):8627-8637.
PMID: 39179864
Background: Ferroptosis is a cell death caused by iron-dependent accumulation of lipid peroxidation. Transferrin receptor (TFR) is a ferroptosis-related protein responsible for iron transport. The detailed biologic role of TFR...
7.
Yoshiya S, Itoh S, Toshima T, Bekki Y, Izumi T, Iseda N, et al.
Surg Today
. 2024 Aug;
PMID: 39158605
Purpose: Infectious complications, particularly post-transplant sepsis, have a critical impact on postoperative outcomes. This study examined the effects of perioperative synbiotic treatment on postoperative outcomes in patients receiving early enteral...
8.
Ninomiya M, Itoh S, Takeishi K, Toshima T, Yoshiya S, Morita K, et al.
Surg Today
. 2024 Aug;
55(3):425-433.
PMID: 39158604
Purpose: We aimed to define borderline resectable colorectal liver metastases (CRLM) based on the analysis of risk factors for early surgical failure and investigate the efficacy of neoadjuvant chemotherapy in...
9.
Toshida K, Itoh S, Toshima T, Yoshiya S, Bekki Y, Izumi T, et al.
Surg Today
. 2024 Aug;
55(3):370-379.
PMID: 39097843
Purpose: Treatment outcomes are predicted by analyzing peripheral blood markers such as serum lactate dehydrogenase (LDH). We conducted this study to investigate whether serum LDH levels can predict the prognosis...
10.
Kurihara T, Itoh S, Toshima T, Toshida K, Tomiyama T, Kosai Y, et al.
Liver Transpl
. 2024 Jul;
PMID: 38995149
Liver transplantation is the definitive treatment for advanced liver cirrhosis with portal hypertension. In Japan, the scarcity of deceased donors leads to reliance on living donors, often resulting in smaller...